成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook >> journal list >> Journal of Drugs in Dermatology >>article
Journal of Drugs in Dermatology

Journal of Drugs in Dermatology

IF: 1.5
Download PDF

Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream.

Published:1 May 2005 DOI: PMID: 15898289
Debra Breneman, Alan B Fleischer, David Kaplan, Mark Lebwohl, Bruce Miller, David Pariser, Toivo Rist, L Swinyer, Yin Liu, Valerie Foley

Abstract

Atopic dermatitis (AD) is a chronic inflammatory and pruritic skin disorder marked by alternating periods of relapse and remission. This multicenter, randomized, active- and vehicle-controlled, investigator-blinded study compared the efficacy and safety of clobetasol propionate lotion to clobetasol propionate cream formulation and lotion vehicle in the treatment of moderate to severe AD. A total of 229 subjects applied treatment twice-daily for 2 weeks. Clobetasol propionate lotion was significantly more effective than its lotion vehicle at 2 weeks and comparable to the cream formulation. Clinical success after a 2-week, treatment-free follow-up period was greater in the clobetasol propionate lotion group than in the cream group. Clobetasol propionate lotion is effective, safe, well tolerated and offers a better remission profile in the treatment of moderate to severe AD as compared to clobetasol propionate emollient cream.

Substances (1)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Clobetasol propionate 25122-46-7 C25H32ClFO5 757 suppliers $29.00-$2000.00

Similar articles

IF:2.1

Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.

Cutis Jacques Decroix, Henrik Pres,etc Published: 1 September 2004
IF:0

Clobetasol Propionate

Definitions Published: 7 February 2020